With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Investigators studied how Mohs micrographic surgery with melanocytic immunostains affected local recurrence and mortality rates in patients with invasive melanoma.

The study is looking at the combination of BNT111 with Regeneron's PD-1 inhibitor Libtayo (cemiplimab) in 184 patients with advanced melanoma who have relapsed after or not responded to treatment ...

Better outcomes were instead reported for the BCG-alone arm. Another Phase III study with Canvaxin in melanoma patients (stage IV; n = 496) was also stopped prematurely in 2005. Patients in the ...

Sentinel lymph node biopsy was not considered, because of the absence of lymphadenopathy and because the thickness was less than 1 mm. The differential diagnosis of malignant melanoma includes ...

Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine ... combined with Merck’s PD-1 inhibitor Keytruda and compared ...

Perspective Therapeutics is a biotech company with promising oncology applications in radiopharmaceuticals. Find out why I ...

In the recent clinical trial, which involved 676 patients who had unresectable stage ... previous melanoma trials. The median survival time for patients receiving ipilimumab was 10.1 months ...

Four oncologists from the Sarah Cannon Research Institute in Tennessee shared with Fox News Digital what they see as the most ...

JULIAN Lennon detailed his emergency surgery that last seven hours after discovering a mole on his arm was cancerous. The ...

A Chicago woman was just weeks away from giving birth when a nagging cough led to a shocking medical discovery. MaKenna ...

A Chicago woman was just weeks away from giving birth when a nagging cough led to a shocking medical discovery. MaKenna Lauterbach shared her harrowing story with Fox News Digital.